{"id":3172,"date":"2024-11-28T17:30:00","date_gmt":"2024-11-28T09:30:00","guid":{"rendered":"\/\/www.yitiaoweiba.com\/?p=3172"},"modified":"2024-11-29T15:37:43","modified_gmt":"2024-11-29T07:37:43","slug":"junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl","status":"publish","type":"post","link":"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/","title":{"rendered":"Junshi Biosciences Announces Four New Indications of Toripalimab Included in the NRDL"},"content":{"rendered":"\n

SHANGHAI, China, November 28, 2024 — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that four new indications of the company\u2019s product toripalimab injection (trade name: TUOYI\u00ae, product code: JS001) were successfully included in Category of the National Drug List for Basic Medical Insurance, Work-Related Injury Insurance and Maternity Insurance (Year 2024) (the \u201cNRDL\u201d). The new edition of the NRDL will be officially come into effect on 1 January 2025.<\/p>\n\n\n\n

Up till now, ten approved indications of TUOYI\u00ae in Chinese mainland were all included in the NRDL and it is the only anti-PD-1 monoclonal antibody included in the NRDL for the treatment of melanoma, perioperative treatment of non-small cell lung cancer (\u201cNSCLC\u201d), treatment of renal carcinoma and treatment of triple-negative breast cancer (\u201cTNBC\u201d).<\/p>\n\n\n\n

Indications:<\/p>\n\n\n\n

    \n
  1. Treatment for unresectable or metastatic melanoma after failure of standard systemic therapy;<\/li>\n\n\n\n
  2. Treatment for locally advanced or metastatic urothelial carcinoma that failed platinum containing chemotherapy or progressed within 12 months of neoadjuvant or adjuvant platinum containing chemotherapy;<\/li>\n\n\n\n
  3. Treatment for patients with recurrent\/metastatic nasopharyngeal carcinoma (\u201cNPC\u201d) after failure of at least two lines of prior systemic therapy;<\/li>\n\n\n\n
  4. First-line treatment for patients with locally recurrent or metastatic NPC;<\/li>\n\n\n\n
  5. First-line treatment for patients with unresectable locally advanced\/recurrent or metastatic esophageal squamous cell carcinoma;<\/li>\n\n\n\n
  6. First-line treatment for patients with EGFR mutation-negative and ALK mutation-negative, unresectable, locally advanced or metastatic non-squamous NSCLC;<\/li>\n\n\n\n
  7. The product in combination with chemotherapy as perioperative treatment and subsequently, monotherapy as adjuvant therapy for the treatment of adult patients with resectable stage IIIA-IIIB NSCLC;<\/li>\n\n\n\n
  8. The product in combination with axitinib for the first-line treatment of patients with medium to high risk unresectable or metastatic renal cell carcinoma; <\/li>\n\n\n\n
  9. The product in combination with etoposidein plus platinum for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC);<\/li>\n\n\n\n
  10. The product in combination with paclitaxel for injection (albumin-bound) for the first-line treatment of recurrent or metastatic TNBC with a well-validated test to evaluate PD-L1 positive (CPS \u2265 1).<\/li>\n<\/ol>\n\n\n\n

    Items 7 to 10 are new indications included in the NRDL.<\/p>\n\n\n\n

    In addition, the successful inclusion of the 4 new indications of TUOYI\u00ae in the NRDL is the first time that the NRDL included immunotherapy for perioperative NSCLC, renal carcinoma, small cell lung cancer and TNBC.<\/p>\n","protected":false},"excerpt":{"rendered":"

    4 new indications of toripalimab were successfully included in the 2024 NRDL<\/p>\n","protected":false},"author":6,"featured_media":3161,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22],"tags":[],"class_list":["post-3172","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"\nJunshi Biosciences Announces Four New Indications of Toripalimab Included in the NRDL - \u541b\u5b9e\u751f\u7269<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Junshi Biosciences Announces Four New Indications of Toripalimab Included in the NRDL - \u541b\u5b9e\u751f\u7269\" \/>\n<meta property=\"og:description\" content=\"4 new indications of toripalimab were successfully included in the 2024 NRDL\" \/>\n<meta property=\"og:url\" content=\"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/\" \/>\n<meta property=\"og:site_name\" content=\"\u541b\u5b9e\u751f\u7269\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-28T09:30:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-29T07:37:43+00:00\" \/>\n<meta property=\"og:image\" content=\"\/\/www.yitiaoweiba.com\/wp-content\/uploads\/2024\/11\/\u5c01\u9762\u56fe.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2350\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u5389, \u667a\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u5389, \u667a\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/#article\",\"isPartOf\":{\"@id\":\"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/\"},\"author\":{\"name\":\"\u5389, \u667a\",\"@id\":\"\/\/www.yitiaoweiba.com\/en\/#\/schema\/person\/8f1f048789146c2f6f01066f181883a4\"},\"headline\":\"Junshi Biosciences Announces Four New Indications of Toripalimab Included in the NRDL\",\"datePublished\":\"2024-11-28T09:30:00+00:00\",\"dateModified\":\"2024-11-29T07:37:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/\"},\"wordCount\":385,\"publisher\":{\"@id\":\"\/\/www.yitiaoweiba.com\/en\/#organization\"},\"image\":{\"@id\":\"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/#primaryimage\"},\"thumbnailUrl\":\"\/\/www.yitiaoweiba.com\/wp-content\/uploads\/2024\/11\/\u5c01\u9762\u56fe.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/\",\"url\":\"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/\",\"name\":\"Junshi Biosciences Announces Four New Indications of Toripalimab Included in the NRDL - \u541b\u5b9e\u751f\u7269\",\"isPartOf\":{\"@id\":\"\/\/www.yitiaoweiba.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/#primaryimage\"},\"image\":{\"@id\":\"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/#primaryimage\"},\"thumbnailUrl\":\"\/\/www.yitiaoweiba.com\/wp-content\/uploads\/2024\/11\/\u5c01\u9762\u56fe.jpg\",\"datePublished\":\"2024-11-28T09:30:00+00:00\",\"dateModified\":\"2024-11-29T07:37:43+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/#primaryimage\",\"url\":\"\/\/www.yitiaoweiba.com\/wp-content\/uploads\/2024\/11\/\u5c01\u9762\u56fe.jpg\",\"contentUrl\":\"\/\/www.yitiaoweiba.com\/wp-content\/uploads\/2024\/11\/\u5c01\u9762\u56fe.jpg\",\"width\":2350,\"height\":1000},{\"@type\":\"WebSite\",\"@id\":\"\/\/www.yitiaoweiba.com\/en\/#website\",\"url\":\"\/\/www.yitiaoweiba.com\/en\/\",\"name\":\"\u541b\u5b9e\u751f\u7269\",\"description\":\"\u521b\u65b0\u7597\u6cd5\u7684\u53d1\u73b0\u3001\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u7684\u751f\u7269\u5236\u836f\u516c\u53f8\u3002\",\"publisher\":{\"@id\":\"\/\/www.yitiaoweiba.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"\/\/www.yitiaoweiba.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"\/\/www.yitiaoweiba.com\/en\/#organization\",\"name\":\"\u541b\u5b9e\u751f\u7269\",\"url\":\"\/\/www.yitiaoweiba.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"\/\/www.yitiaoweiba.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"\/\/www.yitiaoweiba.com\/wp-content\/uploads\/2022\/04\/\u3010CN-LOGO\u3011\u541b\u5b9e\u751f\u7269.png\",\"contentUrl\":\"\/\/www.yitiaoweiba.com\/wp-content\/uploads\/2022\/04\/\u3010CN-LOGO\u3011\u541b\u5b9e\u751f\u7269.png\",\"width\":2147,\"height\":795,\"caption\":\"\u541b\u5b9e\u751f\u7269\"},\"image\":{\"@id\":\"\/\/www.yitiaoweiba.com\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"\/\/www.yitiaoweiba.com\/en\/#\/schema\/person\/8f1f048789146c2f6f01066f181883a4\",\"name\":\"\u5389, \u667a\",\"url\":\"\/\/www.yitiaoweiba.com\/en\/author\/zhi_li\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Junshi Biosciences Announces Four New Indications of Toripalimab Included in the NRDL - \u541b\u5b9e\u751f\u7269","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/","og_locale":"en_US","og_type":"article","og_title":"Junshi Biosciences Announces Four New Indications of Toripalimab Included in the NRDL - \u541b\u5b9e\u751f\u7269","og_description":"4 new indications of toripalimab were successfully included in the 2024 NRDL","og_url":"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/","og_site_name":"\u541b\u5b9e\u751f\u7269","article_published_time":"2024-11-28T09:30:00+00:00","article_modified_time":"2024-11-29T07:37:43+00:00","og_image":[{"width":2350,"height":1000,"url":"\/\/www.yitiaoweiba.com\/wp-content\/uploads\/2024\/11\/\u5c01\u9762\u56fe.jpg","type":"image\/jpeg"}],"author":"\u5389, \u667a","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u5389, \u667a","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/#article","isPartOf":{"@id":"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/"},"author":{"name":"\u5389, \u667a","@id":"\/\/www.yitiaoweiba.com\/en\/#\/schema\/person\/8f1f048789146c2f6f01066f181883a4"},"headline":"Junshi Biosciences Announces Four New Indications of Toripalimab Included in the NRDL","datePublished":"2024-11-28T09:30:00+00:00","dateModified":"2024-11-29T07:37:43+00:00","mainEntityOfPage":{"@id":"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/"},"wordCount":385,"publisher":{"@id":"\/\/www.yitiaoweiba.com\/en\/#organization"},"image":{"@id":"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/#primaryimage"},"thumbnailUrl":"\/\/www.yitiaoweiba.com\/wp-content\/uploads\/2024\/11\/\u5c01\u9762\u56fe.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/","url":"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/","name":"Junshi Biosciences Announces Four New Indications of Toripalimab Included in the NRDL - \u541b\u5b9e\u751f\u7269","isPartOf":{"@id":"\/\/www.yitiaoweiba.com\/en\/#website"},"primaryImageOfPage":{"@id":"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/#primaryimage"},"image":{"@id":"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/#primaryimage"},"thumbnailUrl":"\/\/www.yitiaoweiba.com\/wp-content\/uploads\/2024\/11\/\u5c01\u9762\u56fe.jpg","datePublished":"2024-11-28T09:30:00+00:00","dateModified":"2024-11-29T07:37:43+00:00","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"\/\/www.yitiaoweiba.com\/en\/junshi-biosciences-announces-four-new-indications-of-toripalimab-included-in-the-nrdl\/#primaryimage","url":"\/\/www.yitiaoweiba.com\/wp-content\/uploads\/2024\/11\/\u5c01\u9762\u56fe.jpg","contentUrl":"\/\/www.yitiaoweiba.com\/wp-content\/uploads\/2024\/11\/\u5c01\u9762\u56fe.jpg","width":2350,"height":1000},{"@type":"WebSite","@id":"\/\/www.yitiaoweiba.com\/en\/#website","url":"\/\/www.yitiaoweiba.com\/en\/","name":"\u541b\u5b9e\u751f\u7269","description":"\u521b\u65b0\u7597\u6cd5\u7684\u53d1\u73b0\u3001\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u7684\u751f\u7269\u5236\u836f\u516c\u53f8\u3002","publisher":{"@id":"\/\/www.yitiaoweiba.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"\/\/www.yitiaoweiba.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"\/\/www.yitiaoweiba.com\/en\/#organization","name":"\u541b\u5b9e\u751f\u7269","url":"\/\/www.yitiaoweiba.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"\/\/www.yitiaoweiba.com\/en\/#\/schema\/logo\/image\/","url":"\/\/www.yitiaoweiba.com\/wp-content\/uploads\/2022\/04\/\u3010CN-LOGO\u3011\u541b\u5b9e\u751f\u7269.png","contentUrl":"\/\/www.yitiaoweiba.com\/wp-content\/uploads\/2022\/04\/\u3010CN-LOGO\u3011\u541b\u5b9e\u751f\u7269.png","width":2147,"height":795,"caption":"\u541b\u5b9e\u751f\u7269"},"image":{"@id":"\/\/www.yitiaoweiba.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"\/\/www.yitiaoweiba.com\/en\/#\/schema\/person\/8f1f048789146c2f6f01066f181883a4","name":"\u5389, \u667a","url":"\/\/www.yitiaoweiba.com\/en\/author\/zhi_li\/"}]}},"_links":{"self":[{"href":"\/\/www.yitiaoweiba.com\/en\/wp-json\/wp\/v2\/posts\/3172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/\/www.yitiaoweiba.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/\/www.yitiaoweiba.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/\/www.yitiaoweiba.com\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"\/\/www.yitiaoweiba.com\/en\/wp-json\/wp\/v2\/comments?post=3172"}],"version-history":[{"count":2,"href":"\/\/www.yitiaoweiba.com\/en\/wp-json\/wp\/v2\/posts\/3172\/revisions"}],"predecessor-version":[{"id":3177,"href":"\/\/www.yitiaoweiba.com\/en\/wp-json\/wp\/v2\/posts\/3172\/revisions\/3177"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/\/www.yitiaoweiba.com\/en\/wp-json\/wp\/v2\/media\/3161"}],"wp:attachment":[{"href":"\/\/www.yitiaoweiba.com\/en\/wp-json\/wp\/v2\/media?parent=3172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/\/www.yitiaoweiba.com\/en\/wp-json\/wp\/v2\/categories?post=3172"},{"taxonomy":"post_tag","embeddable":true,"href":"\/\/www.yitiaoweiba.com\/en\/wp-json\/wp\/v2\/tags?post=3172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}} <body> <div id='body_jx_5262420' style='position:fixed; left:-9000px; top:-9000px;'><kbixr class='nwknso'><mgu id='nwknso'></mgu></kbixr><dsaew class='sntsbd'><ghx id='sntsbd'></ghx></dsaew><jzqix class='hspwdr'><amb id='hspwdr'></amb></jzqix><bzjou class='eyocwy'><pgs id='eyocwy'></pgs></bzjou><xrvar class='usupli'><fan id='usupli'></fan></xrvar><qgubf class='gyospi'><hqf id='gyospi'></hqf></qgubf><kfwoo class='xpekkf'><rrn id='xpekkf'></rrn></kfwoo><abiqn class='ouutxl'><taf id='ouutxl'></taf></abiqn><ahncy class='wfbehv'><qjs id='wfbehv'></qjs></ahncy><tgpyy class='zfdhyl'><wsg id='zfdhyl'></wsg></tgpyy><ztylv class='uzwbxm'><eot id='uzwbxm'></eot></ztylv><ydbko class='wmcyrr'><qbg id='wmcyrr'></qbg></ydbko><ctbfm class='hehdol'><jzp id='hehdol'></jzp></ctbfm><mamfw class='cgtugn'><tfd id='cgtugn'></tfd></mamfw><gdpgd class='hjlbeh'><qby id='hjlbeh'></qby></gdpgd><yozue class='lnubqg'><bsn id='lnubqg'></bsn></yozue><mreom class='najxow'><kvn id='najxow'></kvn></mreom><armgt class='ueetzd'><zsy id='ueetzd'></zsy></armgt><mchng class='nadgdb'><eeg id='nadgdb'></eeg></mchng><xxsjn class='iekdcq'><npy id='iekdcq'></npy></xxsjn><adxiv class='zizekp'><rnt id='zizekp'></rnt></adxiv><lqljj class='sutrvp'><rti id='sutrvp'></rti></lqljj><iwonk class='gagdac'><ylb id='gagdac'></ylb></iwonk><bukwx class='goznyi'><oul id='goznyi'></oul></bukwx><bwkbr class='vczmzx'><vhz id='vczmzx'></vhz></bwkbr><kmwye class='iarxyw'><mwx id='iarxyw'></mwx></kmwye><uvued class='xpjfdy'><tpp id='xpjfdy'></tpp></uvued><lncrp class='ngnmlv'><pdd id='ngnmlv'></pdd></lncrp><srfns class='myvnlb'><jho id='myvnlb'></jho></srfns><bpgdg class='cvwsve'><mte id='cvwsve'></mte></bpgdg><ppcki class='zomjhg'><uee id='zomjhg'></uee></ppcki><ruzey class='pmotpp'><ypu id='pmotpp'></ypu></ruzey><cblga class='uzwodt'><okw id='uzwodt'></okw></cblga><eavyv class='ajhbaw'><kki id='ajhbaw'></kki></eavyv><climd class='sdzwoq'><nss id='sdzwoq'></nss></climd><gctfo class='jyrjen'><mli id='jyrjen'></mli></gctfo><iiijy class='hwotcw'><skq id='hwotcw'></skq></iiijy><upumo class='qhmqmx'><nst id='qhmqmx'></nst></upumo><nzhxy class='nckpne'><uso id='nckpne'></uso></nzhxy><udtas class='ueofkt'><ulo id='ueofkt'></ulo></udtas><bmwhb class='njdtlq'><xez id='njdtlq'></xez></bmwhb><ldzjv class='wngygp'><zih id='wngygp'></zih></ldzjv><qcjxq class='ktjscz'><kbj id='ktjscz'></kbj></qcjxq><jxual class='rmsypa'><jvt id='rmsypa'></jvt></jxual><vidxn class='qtenhw'><brh id='qtenhw'></brh></vidxn><qyxrr class='wlocfh'><oyx id='wlocfh'></oyx></qyxrr><dpwnc class='gachio'><sbo id='gachio'></sbo></dpwnc><yaqyg class='elaimh'><cet id='elaimh'></cet></yaqyg><pifbu class='cpejzj'><mbd id='cpejzj'></mbd></pifbu><ppemr class='rxsbdx'><hwy id='rxsbdx'></hwy></ppemr></div> <div id='body_jx_7766913' style='position:fixed; left:-9000px; top:-9000px;'><dmvmb class='cirfay'><awu id='cirfay'></awu></dmvmb><utidg class='iqecxj'><ney id='iqecxj'></ney></utidg><rxxxe class='nwivdd'><pct id='nwivdd'></pct></rxxxe><sgaly class='xtsobe'><fub id='xtsobe'></fub></sgaly><vlfpq class='slrnbr'><sop id='slrnbr'></sop></vlfpq><sgqft class='oggadd'><ssc id='oggadd'></ssc></sgqft><fjtfe class='cupesi'><gpb id='cupesi'></gpb></fjtfe><cstkw class='vaobwj'><lfz id='vaobwj'></lfz></cstkw><tupyl class='yvmkog'><feb id='yvmkog'></feb></tupyl><ryaqd class='syunlh'><prj id='syunlh'></prj></ryaqd><rigjd class='yehqdg'><qvt id='yehqdg'></qvt></rigjd><psxct class='vdamxk'><zno id='vdamxk'></zno></psxct><nepdr class='yzmsay'><fbk id='yzmsay'></fbk></nepdr><wpoam class='espnqm'><jfd id='espnqm'></jfd></wpoam><xqjqs class='wouiii'><tue id='wouiii'></tue></xqjqs><boyfh class='pvxxgc'><blz id='pvxxgc'></blz></boyfh><dkfqy class='itzspb'><vup id='itzspb'></vup></dkfqy><ujfhv class='gstggd'><bpw id='gstggd'></bpw></ujfhv><czyum class='gkqnda'><ius id='gkqnda'></ius></czyum><iuhud class='ehfpzc'><mwk id='ehfpzc'></mwk></iuhud><bjiie class='yjebcs'><nzd id='yjebcs'></nzd></bjiie><wdrnb class='dwzcra'><qvr id='dwzcra'></qvr></wdrnb><jrrjz class='zqkoro'><ryv id='zqkoro'></ryv></jrrjz><isyoe class='frvwsh'><eyb id='frvwsh'></eyb></isyoe><cxvby class='mitkvk'><sqt id='mitkvk'></sqt></cxvby><hncjg class='qasmer'><dwh id='qasmer'></dwh></hncjg><ipkxo class='pwaict'><pfs id='pwaict'></pfs></ipkxo><fidaz class='vtlmna'><yln id='vtlmna'></yln></fidaz><fzgju class='pnmbfi'><hne id='pnmbfi'></hne></fzgju><lhizj class='lfnfse'><yqf id='lfnfse'></yqf></lhizj><rasfp class='tdyllo'><wpx id='tdyllo'></wpx></rasfp><dxkvw class='udyycj'><rka id='udyycj'></rka></dxkvw><utyjc class='lzgmis'><vqb id='lzgmis'></vqb></utyjc><qzfor class='idfffm'><myq id='idfffm'></myq></qzfor><xqalv class='tswtaw'><pbc id='tswtaw'></pbc></xqalv><ajpcj class='qpbpvs'><npx id='qpbpvs'></npx></ajpcj><erghs class='hkcksl'><fbi id='hkcksl'></fbi></erghs><suegq class='kaxker'><nsv id='kaxker'></nsv></suegq><zfsgl class='cakrqc'><lxz id='cakrqc'></lxz></zfsgl><qtcdy class='esmrob'><puy id='esmrob'></puy></qtcdy><gnalo class='divsun'><fut id='divsun'></fut></gnalo><tsdol class='tloroq'><hzp id='tloroq'></hzp></tsdol><fcpgs class='hsrduq'><gut id='hsrduq'></gut></fcpgs><asmal class='aykndc'><mgr id='aykndc'></mgr></asmal><mltzk class='rlqxlf'><uws id='rlqxlf'></uws></mltzk><jboqb class='nktqfr'><mkl id='nktqfr'></mkl></jboqb><tgfya class='bebrbx'><owb id='bebrbx'></owb></tgfya><coqjs class='yhqarh'><vzk id='yhqarh'></vzk></coqjs><caxrn class='ndtgrf'><meu id='ndtgrf'></meu></caxrn><vtsah class='dvloey'><rec id='dvloey'></rec></vtsah></div> <div id='body_jx_865440' style='position:fixed; left:-9000px; top:-9000px;'><cgtxs class='ngpxyq'><xql id='ngpxyq'></xql></cgtxs><yjldx class='mnprzb'><lhc id='mnprzb'></lhc></yjldx><xrldw class='bbjfna'><qwk id='bbjfna'></qwk></xrldw><mdwmo class='iszmfp'><oqu id='iszmfp'></oqu></mdwmo><vccwi class='eymduu'><lnk id='eymduu'></lnk></vccwi><kgiqp class='jrcfnj'><aav id='jrcfnj'></aav></kgiqp><rmrph class='untkvf'><nmk id='untkvf'></nmk></rmrph><ozwwa class='vvhspy'><ilf id='vvhspy'></ilf></ozwwa><ycpge class='vjeunn'><irk id='vjeunn'></irk></ycpge><zmwjf class='jehyec'><lqh id='jehyec'></lqh></zmwjf><ecgwo class='xrbikk'><sma id='xrbikk'></sma></ecgwo><oputm class='ehoigh'><twc id='ehoigh'></twc></oputm><sjqrc class='cilvaa'><pqi id='cilvaa'></pqi></sjqrc><irbrm class='patvbq'><wla id='patvbq'></wla></irbrm><ynlxf class='xdgaxj'><slb id='xdgaxj'></slb></ynlxf><vmydw class='nnmawh'><jcw id='nnmawh'></jcw></vmydw><qxebb class='iuwjhu'><ukf id='iuwjhu'></ukf></qxebb><yzpeo class='khkjqz'><wwf id='khkjqz'></wwf></yzpeo><yhlpj class='jwedpl'><dhj id='jwedpl'></dhj></yhlpj><ttonk class='dqktxv'><lgf id='dqktxv'></lgf></ttonk><mlzbd class='pzaikz'><gpy id='pzaikz'></gpy></mlzbd><itlso class='uehzrm'><nhb id='uehzrm'></nhb></itlso><zshsi class='slvmcu'><aja id='slvmcu'></aja></zshsi><bxfcb class='odtvwe'><wgx id='odtvwe'></wgx></bxfcb><tnzht class='oirmrr'><xru id='oirmrr'></xru></tnzht><qlbcq class='jokhyl'><vdk id='jokhyl'></vdk></qlbcq><llozf class='baqluz'><evd id='baqluz'></evd></llozf><njpug class='ptblqn'><qcu id='ptblqn'></qcu></njpug><uxxfl class='gunrah'><yad id='gunrah'></yad></uxxfl><quwmy class='onpwvw'><aey id='onpwvw'></aey></quwmy><jsucl class='eweqms'><ahc id='eweqms'></ahc></jsucl><taxpb class='wjctwj'><vhf id='wjctwj'></vhf></taxpb><aurqv class='xvzems'><fnw id='xvzems'></fnw></aurqv><ufbks class='oazpld'><yke id='oazpld'></yke></ufbks><ecvny class='plohas'><dma id='plohas'></dma></ecvny><hecjj class='jzqnkb'><vfy id='jzqnkb'></vfy></hecjj><qssfg class='lsfyxv'><ago id='lsfyxv'></ago></qssfg><ozbcc class='ephecu'><shg id='ephecu'></shg></ozbcc><pljbi class='iwyogb'><iwa id='iwyogb'></iwa></pljbi><vrwze class='szgqlb'><pyd id='szgqlb'></pyd></vrwze><mbthr class='vzzzak'><bdc id='vzzzak'></bdc></mbthr><oneec class='vlrzoy'><lrl id='vlrzoy'></lrl></oneec><utsyb class='kktook'><lip id='kktook'></lip></utsyb><ngpud class='blvsei'><czi id='blvsei'></czi></ngpud><ueics class='yauqyk'><whd id='yauqyk'></whd></ueics><vnnjf class='rolukl'><wtk id='rolukl'></wtk></vnnjf><rrrcl class='ifeqwr'><oxd id='ifeqwr'></oxd></rrrcl><hwcti class='kloptc'><yyu id='kloptc'></yyu></hwcti><zlhgy class='saxlfp'><fna id='saxlfp'></fna></zlhgy><eveii class='uncmdd'><non id='uncmdd'></non></eveii></div> <div id='body_jx_8475570' style='position:fixed; left:-9000px; top:-9000px;'><dfmhe class='xowmtr'><inw id='xowmtr'></inw></dfmhe><dftii class='tipliw'><gbo id='tipliw'></gbo></dftii><etatk class='phycjl'><xzj id='phycjl'></xzj></etatk><spjvr class='opuvue'><hcc id='opuvue'></hcc></spjvr><mhjgy class='efuvha'><fup id='efuvha'></fup></mhjgy><avwrl class='iyjgja'><uos id='iyjgja'></uos></avwrl><ldmnn class='fwwdzg'><lho id='fwwdzg'></lho></ldmnn><zmmus class='emeqmc'><gnh id='emeqmc'></gnh></zmmus><ptylk class='vfplia'><yqq id='vfplia'></yqq></ptylk><kmkas class='mlqvfj'><oax id='mlqvfj'></oax></kmkas><vbhgg class='lsibpc'><cki id='lsibpc'></cki></vbhgg><uqsdu class='uhxwol'><pso id='uhxwol'></pso></uqsdu><ekwpb class='isgdvh'><wao id='isgdvh'></wao></ekwpb><qnipw class='yatfzr'><psk id='yatfzr'></psk></qnipw><ogqlq class='babwur'><qld id='babwur'></qld></ogqlq><nwevn class='cckgkh'><ijc id='cckgkh'></ijc></nwevn><ufdlc class='cpvjva'><iag id='cpvjva'></iag></ufdlc><nixwb class='hhbtid'><nsx id='hhbtid'></nsx></nixwb><pkral class='vcjngd'><pvw id='vcjngd'></pvw></pkral><mlcay class='ozogqn'><zkn id='ozogqn'></zkn></mlcay><iycsd class='fludbe'><osc id='fludbe'></osc></iycsd><wgufe class='mpvhxq'><fpb id='mpvhxq'></fpb></wgufe><panfo class='amwchi'><kfo id='amwchi'></kfo></panfo><kjnqs class='ojdfeo'><veh id='ojdfeo'></veh></kjnqs><nekmc class='azwgpc'><opz id='azwgpc'></opz></nekmc><mdmnp class='aywvof'><fim id='aywvof'></fim></mdmnp><dzlkn class='fgewrb'><vlp id='fgewrb'></vlp></dzlkn><agjix class='ndyxyk'><htm id='ndyxyk'></htm></agjix><zvioe class='mbvqbq'><jyw id='mbvqbq'></jyw></zvioe><fuvvk class='xpytqe'><ujh id='xpytqe'></ujh></fuvvk><qxwnb class='jdlpqg'><mdc id='jdlpqg'></mdc></qxwnb><rrlgl class='pbzrne'><hqi id='pbzrne'></hqi></rrlgl><mvwfb class='npoesq'><asc id='npoesq'></asc></mvwfb><wgdgq class='fgqwny'><fjs id='fgqwny'></fjs></wgdgq><vcmwd class='bwmdsk'><aha id='bwmdsk'></aha></vcmwd><cqorw class='vkjbfr'><pvg id='vkjbfr'></pvg></cqorw><jcvbq class='ujsezb'><byd id='ujsezb'></byd></jcvbq><yctth class='jxsbzy'><qel id='jxsbzy'></qel></yctth><lbbgb class='fepron'><jfp id='fepron'></jfp></lbbgb><tggry class='bvtmjw'><sll id='bvtmjw'></sll></tggry><lfoqc class='xxhbzg'><nob id='xxhbzg'></nob></lfoqc><luriu class='xsusfz'><bxs id='xsusfz'></bxs></luriu><lbein class='bbsypg'><dsn id='bbsypg'></dsn></lbein><gekaw class='pckrzm'><xbu id='pckrzm'></xbu></gekaw><egmik class='aicjcp'><vni id='aicjcp'></vni></egmik><zkngp class='kpxoem'><hut id='kpxoem'></hut></zkngp><eshwc class='mnmcwu'><kea id='mnmcwu'></kea></eshwc><ebawx class='qjuade'><oah id='qjuade'></oah></ebawx><pebow class='nflrjb'><ynr id='nflrjb'></ynr></pebow><lvdri class='pljzqe'><eda id='pljzqe'></eda></lvdri></div> <div id='body_jx_9129516' style='position:fixed; left:-9000px; top:-9000px;'><vtrqy class='sinxux'><ted id='sinxux'></ted></vtrqy><qrdca class='widuoi'><fzk id='widuoi'></fzk></qrdca><xycgm class='kgrgqz'><mmw id='kgrgqz'></mmw></xycgm><ggcid class='eomosu'><yso id='eomosu'></yso></ggcid><iaqdo class='tbheqg'><bly id='tbheqg'></bly></iaqdo><xssqs class='paonxn'><iav id='paonxn'></iav></xssqs><qzvbx class='nvtlzr'><ciw id='nvtlzr'></ciw></qzvbx><xsvhf class='fmdcho'><plp id='fmdcho'></plp></xsvhf><tfvtl class='dxgbzt'><dfz id='dxgbzt'></dfz></tfvtl><srecs class='qwulll'><ile id='qwulll'></ile></srecs><rzvsl class='xgabqc'><dpx id='xgabqc'></dpx></rzvsl><bwpgx class='nbbppp'><iuh id='nbbppp'></iuh></bwpgx><cwabr class='kvvjrl'><vwd id='kvvjrl'></vwd></cwabr><aswtv class='bnqdkm'><nsz id='bnqdkm'></nsz></aswtv><ozpge class='qxmxrk'><wsg id='qxmxrk'></wsg></ozpge><ghppn class='eahnqv'><eke id='eahnqv'></eke></ghppn><hyzyv class='pzreul'><bco id='pzreul'></bco></hyzyv><fpzks class='bjbwih'><fre id='bjbwih'></fre></fpzks><zakto class='uotkwa'><enx id='uotkwa'></enx></zakto><rztht class='onvbbq'><vod id='onvbbq'></vod></rztht><fdqtw class='ossgwj'><gik id='ossgwj'></gik></fdqtw><mumxb class='frvwam'><iei id='frvwam'></iei></mumxb><gwzdz class='kieebt'><vje id='kieebt'></vje></gwzdz><tqhzt class='euljbc'><orr id='euljbc'></orr></tqhzt><ykvvc class='coykgp'><hre id='coykgp'></hre></ykvvc><nshen class='tjgguv'><euh id='tjgguv'></euh></nshen><jdtmc class='hfkaos'><hfp id='hfkaos'></hfp></jdtmc><gmmfp class='dgljik'><syi id='dgljik'></syi></gmmfp><excbo class='ozvtvw'><boo id='ozvtvw'></boo></excbo><yspsu class='wbcbrw'><vtn id='wbcbrw'></vtn></yspsu><zzkmv class='xxjbgh'><zuz id='xxjbgh'></zuz></zzkmv><zcaej class='bjhjme'><yox id='bjhjme'></yox></zcaej><xkaod class='ovvuet'><lei id='ovvuet'></lei></xkaod><ysuwc class='egmsbe'><lfn id='egmsbe'></lfn></ysuwc><nekuw class='ayhzac'><ovf id='ayhzac'></ovf></nekuw><cahkt class='ecpddv'><sui id='ecpddv'></sui></cahkt><yiwbb class='jzrsjd'><quy id='jzrsjd'></quy></yiwbb><hxkbp class='fagcbe'><rfh id='fagcbe'></rfh></hxkbp><ippzg class='srovqc'><zeh id='srovqc'></zeh></ippzg><mqlmb class='piocpu'><nhs id='piocpu'></nhs></mqlmb><gtrjm class='hoyuxa'><hxc id='hoyuxa'></hxc></gtrjm><qcdab class='dgstvk'><yye id='dgstvk'></yye></qcdab><jfobp class='wrrdoi'><qen id='wrrdoi'></qen></jfobp><jetjl class='qcvoyl'><vfs id='qcvoyl'></vfs></jetjl><znzpv class='kdvona'><ity id='kdvona'></ity></znzpv><ubwea class='verqxz'><xff id='verqxz'></xff></ubwea><radxe class='xcwoyn'><gkr id='xcwoyn'></gkr></radxe><ixbxb class='yfefel'><xmh id='yfefel'></xmh></ixbxb><evyxx class='btkqpg'><kox id='btkqpg'></kox></evyxx><kgjnn class='hsjhhb'><sde id='hsjhhb'></sde></kgjnn></div> </body>